Allergy Therapeutics plc (AIM:AGY)
London
· Delayed Price · Currency is GBP · Price in GBX 11.50
-0.89 (-7.72%)
Mar 9, 2026, 4:35 PM GMT
Allergy Therapeutics Cash Flow Statement
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | -40.13 | -38.62 | -43.07 | -13.78 | 2.89 | Upgrade
|
| Depreciation & Amortization | 3.94 | 3.9 | 3.79 | 3.74 | 3.84 | Upgrade
|
| Other Amortization | 0.23 | 0.42 | 0.43 | 0.42 | 0.29 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.05 | - | - | 0.01 | - | Upgrade
|
| Stock-Based Compensation | 0.87 | 0.76 | 0.11 | 0.47 | 0.64 | Upgrade
|
| Other Operating Activities | 10.27 | 1.71 | 1.84 | 1.02 | -0.64 | Upgrade
|
| Change in Accounts Receivable | 0.27 | 0.14 | 3.38 | -4.25 | 2.14 | Upgrade
|
| Change in Inventory | -1.02 | -1.24 | -0.18 | -0.57 | -1.12 | Upgrade
|
| Change in Accounts Payable | -2.58 | 0.79 | 4.82 | -1.07 | 0.55 | Upgrade
|
| Operating Cash Flow | -28.11 | -32.14 | -28.88 | -14 | 8.59 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | -31.20% | Upgrade
|
| Capital Expenditures | -3.26 | -3.4 | -4.67 | -3.06 | -2.56 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.27 | 2.07 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.16 | - | - | - | - | Upgrade
|
| Other Investing Activities | 0.27 | 0.14 | 0.08 | 0.06 | -0.08 | Upgrade
|
| Investing Cash Flow | -2.89 | -1.2 | -4.59 | -3 | -2.64 | Upgrade
|
| Long-Term Debt Issued | 40.31 | 37.09 | 36 | - | 0.63 | Upgrade
|
| Long-Term Debt Repaid | -7.27 | -4.52 | -11.53 | -2.27 | -2.36 | Upgrade
|
| Net Debt Issued (Repaid) | 33.05 | 32.57 | 24.47 | -2.27 | -1.74 | Upgrade
|
| Issuance of Common Stock | - | 2.42 | 7 | 0 | 0 | Upgrade
|
| Other Financing Activities | -1.88 | -3.56 | -3.67 | -0.54 | -0.49 | Upgrade
|
| Financing Cash Flow | 31.16 | 31.43 | 27.8 | -2.81 | -2.22 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.29 | -0.02 | 0 | 0.05 | -0.42 | Upgrade
|
| Net Cash Flow | -0.13 | -1.93 | -5.67 | -19.76 | 3.31 | Upgrade
|
| Free Cash Flow | -31.37 | -35.54 | -33.55 | -17.06 | 6.03 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -41.03% | Upgrade
|
| Free Cash Flow Margin | -57.00% | -64.38% | -56.30% | -23.44% | 7.15% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.05 | -0.03 | 0.01 | Upgrade
|
| Cash Interest Paid | 1.16 | 2.5 | 3.16 | 0.54 | 0.49 | Upgrade
|
| Cash Income Tax Paid | 0.57 | 0.15 | 0.45 | 0.21 | -0.04 | Upgrade
|
| Levered Free Cash Flow | -12.86 | -24.11 | -19.5 | -11.48 | 5.55 | Upgrade
|
| Unlevered Free Cash Flow | -8.88 | -21.75 | -18.15 | -11.14 | 5.79 | Upgrade
|
| Change in Working Capital | -3.33 | -0.31 | 8.02 | -5.89 | 1.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.